Bard Associates’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $337K | Sell |
|
|||||
|
2023
Q3 | $153K | Sell |
|
|||||
|
2023
Q2 | $267K | Hold |
|
|||||
|
2023
Q1 | $90.2K | Hold |
|
|||||
|
2022
Q4 | $107K | Sell |
|
|||||
|
2022
Q3 | $261K | Hold |
|
|||||
|
2022
Q2 | $260K | Buy |
|
|||||
|
2022
Q1 | $301K | Hold |
|
|||||
|
2021
Q4 | $303K | Hold |
|
|||||
|
2021
Q3 | $258K | Buy |
|
|||||
|
2021
Q2 | $207K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $35K | Sell |
|
|||||
|
2020
Q2 | $63K | Buy |
|
|||||
|
2020
Q1 | $81K | Sell |
|
|||||
|
2019
Q4 | $125K | Sell |
|
|||||
|
2019
Q3 | $152K | Sell |
|
|||||
|
2019
Q2 | $144K | Sell |
|
|||||
|
2019
Q1 | $158K | Sell |
|
|||||
|
2018
Q4 | $169K | Sell |
|
|||||
|
2018
Q3 | $325K | Hold |
|
|||||
|
2018
Q2 | $189K | Sell |
|
|||||
|
2018
Q1 | $112K | Buy |
|
|||||
|
2017
Q4 | $89K | Sell |
|
|||||
|
2017
Q3 | $101K | Sell |
|
|||||
|
2017
Q2 | $154K | Sell |
|
|||||
|
2017
Q1 | $157K | Sell |
|
|||||
|
2016
Q4 | $173K | Sell |
|
|||||
|
2016
Q3 | $314K | Sell |
|
|||||
|
2016
Q2 | $299K | Sell |
|
|||||
|
2016
Q1 | $300K | Buy |
|
|||||
|
2015
Q4 | $346K | Sell |
|
|||||
|
2015
Q3 | $266K | Hold |
|
|||||
|
2015
Q2 | $274K | Sell |
|
|||||
|
2015
Q1 | $294K | Sell |
|
|||||
|
2014
Q4 | $310K | Hold |
|
|||||
|
2014
Q3 | $334K | Sell |
|
|||||
|
2014
Q2 | $329K | Sell |
|
|||||
|
2014
Q1 | $323K | Hold |
|
|||||
|
2013
Q4 | $328K | Sell |
|
|||||
|
2013
Q3 | $332K | Sell |
|
|||||
|
2013
Q2 | $323K | Buy |
|